Literature DB >> 8591819

Candidate gene studies in pedigrees with maturity-onset diabetes of the young not linked with glucokinase.

Y Zhang1, M Warren-Perry, P J Saker, A T Hattersley, A D Mackie, J D Baird, R H Greenwood, M Stoffel, G I Bell, R C Turner.   

Abstract

Maturity-onset diabetes of the young (MODY) is a form of non-insulin-dependent diabetes mellitus characterised by an early age of onset and an autosomal dominant mode of inheritance. Only a proportion of cases are due to mutations in the glucokinase gene. We have studied five Caucasian MODY families, including the first MODY family to be described, with five candidate genes implicated in regulation of insulin secretion. The affected subjects showed more marked hyperglycaemia than that found in subjects with glucokinase mutations. We assessed polymorphic markers close to the genes for glucokinase, hexokinase II, adenosine deaminase, pituitary adenylate cyclase-activating polypeptide receptor, and glucagon-like peptide-1 receptor. Linkage analysis with diabetes gave cumulative log of the odds (LOD) scores of less than -3, implying that mutations in these genes are unlikely to provide a major genetic contribution to this form of MODY.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591819     DOI: 10.1007/bf00402175

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

Review 1.  Type 2 (non-insulin-dependent) diabetes mellitus. New genetics for old nightmares.

Authors:  S O'Rahilly; J S Wainscoat; R C Turner
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

2.  Mild familial diabetes with dominant inheritance.

Authors:  R B Tattersall
Journal:  Q J Med       Date:  1974-04

3.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus.

Authors:  P Froguel; M Vaxillaire; F Sun; G Velho; H Zouali; M O Butel; S Lesage; N Vionnet; K Clément; F Fougerousse
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

4.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

Authors:  P Froguel; H Zouali; N Vionnet; G Velho; M Vaxillaire; F Sun; S Lesage; M Stoffel; J Takeda; P Passa
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

5.  Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins.

Authors:  B Newman; J V Selby; M C King; C Slemenda; R Fabsitz; G D Friedman
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

6.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q.

Authors:  G I Bell; K S Xiang; M V Newman; S H Wu; L G Wright; S S Fajans; R S Spielman; N J Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 7.  Diabetes: the genetic connections.

Authors:  D A Pyke
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

8.  Distribution of type II diabetes in nuclear families.

Authors:  J T Cook; A T Hattersley; J C Levy; P Patel; J S Wainscoat; T D Hockaday; R C Turner
Journal:  Diabetes       Date:  1993-01       Impact factor: 9.461

9.  Glucokinase activity in isolated islets from obese fa/fa Zucker rats.

Authors:  C B Chan
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

10.  UK Prospective Diabetes Study. V. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet 4-cell function. Multi-centre study.

Authors: 
Journal:  Diabet Med       Date:  1988 Jul-Aug       Impact factor: 4.359

View more
  2 in total

1.  Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.

Authors:  M Lehto; T Tuomi; M M Mahtani; E Widén; C Forsblom; L Sarelin; M Gullström; B Isomaa; M Lehtovirta; A Hyrkkö; T Kanninen; M Orho; S Manley; R C Turner; T Brettin; A Kirby; J Thomas; G Duyk; E Lander; M R Taskinen; L Groop
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 2.  Glucagon-like peptide 1 (GLP-1) and metabolic diseases.

Authors:  C M Rotella; L Pala; E Mannucci
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.